New York State Common Retirement Fund’s Arcus Biosciences RCUS Stock Holding History

New York State Common Retirement Fund’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$563K	Sell	26,054 -16,948	-39%	-$366K	﹤0.01%	1864
2025 Q4	$1.02M	Buy	43,002 +21,148	+97%	+$431K	﹤0.01%	1695
2025 Q3	$297K	Buy	21,854 +8,300	+61%	+$86.3K	﹤0.01%	2126
2025 Q2	$110K	Hold	13,554	–	–	﹤0.01%	2522
2025 Q1	$106K	Hold	13,554	–	–	﹤0.01%	2482
2024 Q4	$202K	Hold	13,554	–	–	﹤0.01%	2290
2024 Q3	$207K	Sell	13,554 -7,200	-35%	-$114K	﹤0.01%	2281
2024 Q2	$316K	Buy	20,754 +454	+2%	+$7.33K	﹤0.01%	2227
2024 Q1	$383K	Hold	20,300	–	–	﹤0.01%	2179
2023 Q4	$388K	Sell	20,300 -556	-3%	-$8.89K	﹤0.01%	2198
2023 Q3	$374K	Sell	20,856 -15,256	-42%	-$307K	﹤0.01%	2168
2023 Q2	$733K	Sell	36,112 -13,347	-27%	-$254K	﹤0.01%	1915
2023 Q1	$902K	Sell	49,459 -2,818	-5%	-$53.9K	﹤0.01%	1903
2022 Q4	$1.08M	Buy	52,277 +3,348	+7%	+$92.1K	﹤0.01%	1931
2022 Q3	$1.28M	Buy	48,929 +2,853	+6%	+$75.5K	﹤0.01%	1853
2022 Q2	$1.17M	Buy	46,076 +4,031	+10%	+$98.7K	﹤0.01%	1928
2022 Q1	$1.33M	Buy	42,045 +9,375	+29%	+$314K	﹤0.01%	1953
2021 Q4	$1.32M	Sell	32,670 -85	-0.3%	-$3.3K	﹤0.01%	1994
2021 Q3	$1.14M	Sell	32,755 -5,804	-15%	-$181K	﹤0.01%	2061
2021 Q2	$1.06M	Buy	38,559 +359	+0.9%	+$10.3K	﹤0.01%	2206
2021 Q1	$1.07M	Hold	38,200	–	–	﹤0.01%	2096
2020 Q4	$992K	Buy	38,200 +8,900	+30%	+$215K	﹤0.01%	2051
2020 Q3	$502K	Hold	29,300	–	–	﹤0.01%	2214
2020 Q2	$725K	Hold	29,300	–	–	﹤0.01%	2038
2020 Q1	$407K	Hold	29,300	–	–	﹤0.01%	2145
2019 Q4	$296K	Sell	29,300 -1,900	-6%	-$16K	﹤0.01%	2550
2019 Q3	$284K	Hold	31,200	–	–	﹤0.01%	2594
2019 Q2	$248K	Hold	31,200	–	–	﹤0.01%	2713
2019 Q1	$390K	Buy	31,200 +24,900	+395%	+$270K	﹤0.01%	2420
2018 Q4	$68K	Hold	6,300	–	–	﹤0.01%	3054
2018 Q3	$88K	Hold	6,300	–	–	﹤0.01%	3062
2018 Q2	$77K	Buy	+6,300	New	+$98.9K	﹤0.01%	3119

Other funds holding RCUS

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

New York State Common Retirement Fund's RCUS Position: Q1 2026 in Review

New York State Common Retirement Fund reduced its Arcus Biosciences (RCUS) stake by 39% in Q1 2026, selling an estimated $366K and leaving 26,054 shares worth $563K. The position accounts for ﹤0.01% of the portfolio, ranked #1864.

New York State Common Retirement Fund first reported a position in RCUS in Q2 2018 and has held it in 32 quarters since. The position peaked at $1.33M in Q1 2022. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

New York State Common Retirement Fund held 26,054 shares of Arcus Biosciences worth $563K as of Q1 2026.
New York State Common Retirement Fund sold 16,948 Arcus Biosciences shares in Q1 2026, an estimated $366K.
Arcus Biosciences made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q1 2026, its #1864 holding.
New York State Common Retirement Fund first reported a position in Arcus Biosciences in Q2 2018 and has held it in 32 quarters since.
New York State Common Retirement Fund's Arcus Biosciences position peaked at $1.33M in Q1 2022.
210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.